Evidence map›Paper›PMID 36498305›Full record

ArticleInternational journal of environmental research and public health2022

Comparative Biomonitoring of Arsenic Exposure in Mothers and Their Neonates in Comarca Lagunera, Mexico.

José Javier García Salcedo, Taehyun Roh, Lydia Enith Nava Rivera, Nadia Denys Betancourt Martínez, Pilar Carranza Rosales, María Francisco San Miguel Salazar, Mario Alberto Rivera Guillén, Luis Benjamín Serrano Gallardo, María Soñadora Niño Castañeda, Nacny Elena Guzmán Delgado and 3 more

Open access · goldAbstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

José Javier García SalcedoDepartamento de Bioquímica y Farmacología, Centro de Investigaciones Biomédicas, Facultad de Medicina, Universidad Autónoma de Coahuila Torreón, Torreón 27000, Mexico.
Taehyun RohDepartment of Epidemiology and Biostatistics, School of Public Health, Texas A&M University, College Station, TX 77843, USA.ORCID 0000-0003-2755-1841
Lydia Enith Nava RiveraDepartamento de Biología Celular y Ultraestructura, Centro de Investigaciones Biomédicas, Facultad de Medicina, Universidad Autónoma de Coahuila Torreón, Torreón 27000, Mexico.
Nadia Denys Betancourt MartínezDepartamento de Biología Celular y Ultraestructura, Centro de Investigaciones Biomédicas, Facultad de Medicina, Universidad Autónoma de Coahuila Torreón, Torreón 27000, Mexico.ORCID 0000-0001-7288-8705
Pilar Carranza RosalesCentro de Investigaciones Biomédicas del Noreste, Instituto Mexicano del Seguro Social, Monterrey 64000, Mexico.ORCID 0000-0002-8944-9298
María Francisco San Miguel SalazarDepartamento de Bioquímica y Farmacología, Centro de Investigaciones Biomédicas, Facultad de Medicina, Universidad Autónoma de Coahuila Torreón, Torreón 27000, Mexico.
Mario Alberto Rivera GuillénDepartamento de Bioquímica y Farmacología, Centro de Investigaciones Biomédicas, Facultad de Medicina, Universidad Autónoma de Coahuila Torreón, Torreón 27000, Mexico.
Luis Benjamín Serrano GallardoDepartamento de Bioquímica y Farmacología, Centro de Investigaciones Biomédicas, Facultad de Medicina, Universidad Autónoma de Coahuila Torreón, Torreón 27000, Mexico.
María Soñadora Niño CastañedaDepartamento de Biología Celular y Ultraestructura, Centro de Investigaciones Biomédicas, Facultad de Medicina, Universidad Autónoma de Coahuila Torreón, Torreón 27000, Mexico.
Nacny Elena Guzmán DelgadoDivisión de Investigaciones en Salud, Unidad Médica de Alta Especialidad, Hospital de Cardiología #34, Instituto Mexicano del Seguro Social, Monterrey 64000, Mexico.ORCID 0000-0003-2925-0532
Jair Millán OrozcoUnidad Laguna, Universidad Autónoma Agraria Antonio Narro, Raúl López Sánchez, Torreon 27000, Mexico.
Natalia Ortega MoralesDivisión de Investigaciones en Salud, Unidad Médica de Alta Especialidad, Hospital de Cardiología #34, Instituto Mexicano del Seguro Social, Monterrey 64000, Mexico.
Javier Morán MartínezDepartamento de Biología Celular y Ultraestructura, Centro de Investigaciones Biomédicas, Facultad de Medicina, Universidad Autónoma de Coahuila Torreón, Torreón 27000, Mexico.ORCID 0000-0002-6514-238X
Universidad Autónoma de Coahuila · MXMexican Social Security Institute · MXTexas A&M University · USUniversidad Autónoma Agraria Antonio Narro · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple comorbidities related to arsenic exposure through drinking water continue to be public problems worldwide, principally in chronically exposed populations, such as those in the Comarca Lagunera (CL), Mexico. In addition, this relationship could be exacerbated by an early life exposure through the placenta and later through breast milk. This study conducted a comparative analysis of arsenic levels in multiple biological samples from pregnant women and their neonates in the CL and the comparison region, Saltillo. Total arsenic levels in placenta, breast milk, blood, and urine were measured in pregnant women and their neonates from rural areas of seven municipalities of the CL using atomic absorption spectrophotometry with hydride generation methodology. The average concentrations of tAs in drinking water were 47.7 µg/L and 0.05 µg/L in the exposed and non-exposed areas, respectively. Mean levels of tAs were 7.80 µg/kg, 77.04 µg/g-Cr, and 4.30 µg/L in placenta, blood, urine, and breast milk, respectively, in mothers, and 107.92 µg/g-Cr in neonates in the exposed group, which were significantly higher than those in the non-exposed area. High levels of urinary arsenic in neonates were maintained 4 days after birth, demonstrating an early arsenic exposure route through the placenta and breast milk. In addition, our study suggested that breastfeeding may reduce arsenic exposure in infants in arsenic-contaminated areas. Further studies are necessary to follow up on comorbidities later in life in neonates and to provide interventions in this region.

Indexed as

ArsenicDrinking WaterBreast FeedingFemaleHumansInfantInfant, NewbornMexicoMilk, HumanPregnancySpectrophotometry, AtomicArsenicDrinking Waterarsenicbiomonitoringbreast milkdrinking waterneonatespregnancy

Identifiers

PMID36498305
PMCPMC9739351
OpenAlexW4311519416

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.